Results 121 to 130 of about 229,376 (344)

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Cytokine Regulation of Gap Junction Connectivity [PDF]

, 2001
Celia F. Brosnan, Eliana Scemes, David C. Spray   +2 more
openalex   +1 more source

Majorana fermions at odd junctions in a wire network of ferromagnetic impurities

, 2016
We consider a wire network of ferromagnetic impurities on the surface of an $s$-wave superconductor with strong Rashba spin-orbit interaction. Within the topological phase, zero-energy Majorana fermions appear at wire end-points as well as at junctions ...
Björnson, Kristofer, Black-Schaffer, Annica M.   +1 more
core   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Transport and spectroscopic properties of superconductor - ferromagnet - superconductor junctions of $La_{1.9}Sr_{0.1}CuO_4$ - $La_{0.67}Ca_{0.33}MnO_3$ - $La_{1.9}Sr_{0.1}CuO_4$

, 2011
Transport and Conductance spectra measurements of ramp-type junctions made of cuprate superconducting $La_{1.9}Sr_{0.1}CuO_4$ electrodes and a manganite ferromagnetic $La_{0.67}Ca_{0.33}MnO_3$ barrier are reported.
A. F. Andreev, A. F. Andreev, G. Koren, T. Kirzhner   +3 more
core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Modulation of connexin 43 in viral infections

Tumour Virus Research
Connexins are essential for intercellular communication through gap junctions and the maintenance of cellular and tissue homeostasis. Connexin 43 (Cx43) is the most ubiquitously expressed connexin. As well as regulating homeostasis, Cx43 hemichannels and
Harry Scott, Patricia E. Martin, Sheila V. Graham   +2 more
doaj   +1 more source

Scanning Tunneling Spectroscopy in MgB 2

, 2002
We present extensive Scanning Tunneling Spectroscopy (STM/S) measurements at low temperatures in the multiband superconductor MgB$_2$. We find a similar behavior in single crystalline samples and in single grains, which clearly shows the partial ...
An, Armstrong, Badr, Bascones, Binnig, Bouquet, Brinkman, Bud’ko, Canfield, Chen, Choi, Dynes, Eskildsen, G. Rubio-Bollinger, Giubileo, Golubov, H. Suderow, Hess, Iavarone, J.G. Rodrigo, Karapetrov, Kortus, Kotegawa, Kotegawa, Liu, Manzano, Mazin, Mazin, Nagamatsu, Naidyuk, P. Martinez-Samper, Quilty, Rubio-Bollinger, S. Lee, S. Tajima, S. Vieira, Schmidt, Schmidt, Sharoni, Silkin, Suderow, Suderow, Suderow, Suhl, Sung, Szabo, Tsuda, Uchiyama, Wang, Wolf, Yang, Yelland, Zhang   +52 more
core   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source